机构：[a]Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming, China[b]Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Disease[c]Sichuan Institute for Food and Drug Control, Chengdu, China[d]Yunnan Center for Disease Control and Prevention, Kunming, China[e]Department of Burn, The Second Affiliated Hospital, Kunming Medical University，Kunming, China
This work was financially supported by the CAMS Initiative
for Innovative Medicine (2016-I2M-1-019), the National Natural
Science Foundation of China (81773270), the Science and
Technology Project of Yunnan Province (2016FA049), and
Fundamental Research Funds for Institute of Pathogen Biology
of PUMC (2014IPB107).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2020]版：
大类|2 区医学
小类|2 区纳米科技2 区医学：研究与实验
最新[2023]版：
大类|2 区医学
小类|3 区医学：研究与实验3 区纳米科技
第一作者：
第一作者机构：[a]Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming, China[b]Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Disease
通讯作者：
通讯机构：[a]Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming, China[b]Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Disease[*1]Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming, China.
推荐引用方式(GB/T 7714)：
Hanghang Xie,Congyan Shu,Hongmei Bai,et al.A therapeutic HPV16 E7 vaccine in combination with active anti-FGF-2 immunization synergistically elicits robust antitumor immunity in mice.[J].Nanomedicine : nanotechnology, biology, and medicine.2020,29:102254.doi:10.1016/j.nano.2020.102254.
APA：
Hanghang Xie,Congyan Shu,Hongmei Bai,Pengyan Sun,Hongxian Liu...&Yanbing Ma.(2020).A therapeutic HPV16 E7 vaccine in combination with active anti-FGF-2 immunization synergistically elicits robust antitumor immunity in mice..Nanomedicine : nanotechnology, biology, and medicine,29,
MLA：
Hanghang Xie,et al."A therapeutic HPV16 E7 vaccine in combination with active anti-FGF-2 immunization synergistically elicits robust antitumor immunity in mice.".Nanomedicine : nanotechnology, biology, and medicine 29.(2020):102254
